Logo image of DLE.I

DATALEX PLC (DLE.I) Stock Fundamental Analysis

DUB:DLE - Euronext Dublin - IE0000527006 - Common Stock - Currency: EUR

0.35  0 (0%)

Fundamental Rating

1

DLE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 101 industry peers in the Software industry. DLE has a bad profitability rating. Also its financial health evaluation is rather negative. DLE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DLE had negative earnings in the past year.
In the past year DLE has reported a negative cash flow from operations.
DLE had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DLE reported negative operating cash flow in multiple years.
DLE.I Yearly Net Income VS EBIT VS OCF VS FCFDLE.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M

1.2 Ratios

DLE's Return On Assets of -60.77% is on the low side compared to the rest of the industry. DLE is outperformed by 84.85% of its industry peers.
Industry RankSector Rank
ROA -60.77%
ROE N/A
ROIC N/A
ROA(3y)-47.09%
ROA(5y)-45.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DLE.I Yearly ROA, ROE, ROICDLE.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400

1.3 Margins

DLE has a worse Gross Margin (35.89%) than 74.75% of its industry peers.
DLE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for DLE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y28.41%
DLE.I Yearly Profit, Operating, Gross MarginsDLE.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

DLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
DLE has about the same amout of shares outstanding than it did 1 year ago.
DLE has more shares outstanding than it did 5 years ago.
DLE has a worse debt/assets ratio than last year.
DLE.I Yearly Shares OutstandingDLE.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
DLE.I Yearly Total Debt VS Total AssetsDLE.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -3.38, we must say that DLE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.38, DLE is doing worse than 79.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.38
ROIC/WACCN/A
WACC7.07%
DLE.I Yearly LT Debt VS Equity VS FCFDLE.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.31 indicates that DLE may have some problems paying its short term obligations.
DLE's Current ratio of 0.31 is on the low side compared to the rest of the industry. DLE is outperformed by 86.87% of its industry peers.
DLE has a Quick Ratio of 0.31. This is a bad value and indicates that DLE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DLE (0.31) is worse than 86.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
DLE.I Yearly Current Assets VS Current LiabilitesDLE.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

DLE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.26%, which is quite impressive.
DLE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.26%.
DLE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.52% yearly.
EPS 1Y (TTM)38.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.51%
Revenue 1Y (TTM)12.26%
Revenue growth 3Y0.96%
Revenue growth 5Y-8.52%
Sales Q2Q%2.67%

3.2 Future

The Earnings Per Share is expected to grow by 52.55% on average over the next years. This is a very strong growth
DLE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.14% yearly.
EPS Next Y-6.98%
EPS Next 2Y29.4%
EPS Next 3Y52.55%
EPS Next 5YN/A
Revenue Next Year-3.22%
Revenue Next 2Y4.77%
Revenue Next 3Y8.14%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DLE.I Yearly Revenue VS EstimatesDLE.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
DLE.I Yearly EPS VS EstimatesDLE.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DLE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLE.I Price Earnings VS Forward Price EarningsDLE.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DLE.I Per share dataDLE.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1

4.3 Compensation for Growth

DLE's earnings are expected to grow with 52.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.4%
EPS Next 3Y52.55%

More info and screens

0

5. Dividend

5.1 Amount

DLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DATALEX PLC

DUB:DLE (3/7/2025, 7:00:00 PM)

0.35

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-20 2024-09-20
Earnings (Next)06-18 2025-06-18/amc
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners11.64%
Ins Owner ChangeN/A
Market Cap65.85M
Analysts80
Price Target0.48 (37.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.45
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.14
BVpS-0.11
TBVpS-0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.77%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.89%
FCFM N/A
ROA(3y)-47.09%
ROA(5y)-45.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y28.41%
F-Score5
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.95%
Cap/Sales 3.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -3.38
F-Score5
WACC7.07%
ROIC/WACCN/A
Cap/Depr(3y)118%
Cap/Depr(5y)91.7%
Cap/Sales(3y)8.62%
Cap/Sales(5y)6.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1.51%
EPS Next Y-6.98%
EPS Next 2Y29.4%
EPS Next 3Y52.55%
EPS Next 5YN/A
Revenue 1Y (TTM)12.26%
Revenue growth 3Y0.96%
Revenue growth 5Y-8.52%
Sales Q2Q%2.67%
Revenue Next Year-3.22%
Revenue Next 2Y4.77%
Revenue Next 3Y8.14%
Revenue Next 5YN/A
EBIT growth 1Y53.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y68.68%
OCF growth 3YN/A
OCF growth 5YN/A